IRIS PubliCatt

Gremese, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.091
EU - Europa 5.024
AS - Asia 1.211
AF - Africa 97
SA - Sud America 29
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 20
Totale 12.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.026
SE - Svezia 994
IT - Italia 925
DE - Germania 871
CN - Cina 714
PL - Polonia 492
FR - Francia 483
IE - Irlanda 384
UA - Ucraina 364
GB - Regno Unito 181
IN - India 156
FI - Finlandia 113
TR - Turchia 60
CA - Canada 53
BE - Belgio 51
CI - Costa d'Avorio 49
HK - Hong Kong 42
IR - Iran 39
JP - Giappone 37
SA - Arabia Saudita 27
AU - Australia 26
CH - Svizzera 25
CZ - Repubblica Ceca 23
RU - Federazione Russa 22
VN - Vietnam 19
SG - Singapore 17
NL - Olanda 15
PH - Filippine 13
EU - Europa 12
PK - Pakistan 12
ZA - Sudafrica 12
ES - Italia 11
EG - Egitto 10
MY - Malesia 10
CL - Cile 9
GR - Grecia 9
IL - Israele 9
RO - Romania 9
AT - Austria 8
BR - Brasile 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BD - Bangladesh 7
IQ - Iraq 7
TW - Taiwan 7
MX - Messico 6
NG - Nigeria 6
TN - Tunisia 6
CO - Colombia 5
KR - Corea 5
MD - Moldavia 5
NO - Norvegia 5
PT - Portogallo 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
BG - Bulgaria 4
DK - Danimarca 4
RS - Serbia 4
EE - Estonia 3
HU - Ungheria 3
ID - Indonesia 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
LV - Lettonia 3
MA - Marocco 3
NP - Nepal 3
SD - Sudan 3
CM - Camerun 2
KE - Kenya 2
LK - Sri Lanka 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PA - Panama 2
SC - Seychelles 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
KW - Kuwait 1
LT - Lituania 1
MK - Macedonia 1
MM - Myanmar 1
PE - Perù 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 12.500
Salva come PNG Salva come JPEG
Città #
Chandler 1.263
Ashburn 515
Warsaw 460
Dublin 364
Fairfield 244
Ann Arbor 234
Wilmington 234
Dearborn 225
Jacksonville 212
San Mateo 204
Woodbridge 193
New York 179
Nanjing 162
Houston 160
Rome 152
Seattle 140
Boston 136
Milan 130
Beijing 129
Cattolica 124
Princeton 111
Bremen 95
Cambridge 82
Marseille 78
Lawrence 77
Chicago 71
Redwood City 63
Pune 51
Abidjan 49
Izmir 47
Nanchang 46
Brussels 42
Norwalk 41
Munich 38
Hong Kong 36
Hangzhou 35
Redmond 33
Boardman 31
Hebei 31
Kunming 31
Falls Church 27
Helsinki 27
Shenyang 27
Guangzhou 26
Lancaster 26
London 26
Mountain View 26
Los Angeles 24
Hefei 23
Jiaxing 23
Nürnberg 23
Shanghai 22
Tianjin 22
Augusta 20
Andover 19
Kraków 19
Brno 18
Changsha 17
Leawood 17
Washington 17
Busto Arsizio 16
Jinan 16
Kish 16
University Park 16
Toronto 15
San Diego 14
Tokyo 13
Zhengzhou 13
Santa Maria 12
Dammam 11
Detroit 11
Palermo 11
Simi Valley 11
Zurich 11
Fremont 10
Chengdu 9
Delhi 9
Haikou 9
Naples 9
Paris 9
Phoenix 9
Sydney 9
Vancouver 9
Dong Ket 8
Fuzhou 8
Mumbai 8
Ningbo 8
Al Qatif 7
Ardabil 7
Cagliari 7
Edinburgh 7
Oggiono 7
Rozzano 7
Wuhan 7
Amsterdam 6
Bern 6
Changchun 6
Clearwater 6
Dallas 6
Herenthout 6
Totale 7.382
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 411
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 371
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 316
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 294
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 266
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 252
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 204
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 184
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 160
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 131
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 130
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 129
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 124
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 123
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 119
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 116
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 113
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 111
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 110
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 110
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 108
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 107
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 104
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 102
Adult onset Still's disease and pregnancy 99
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 98
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 93
IL COINVOLGIMENTO ARTICOLARE NEL LES: LA FORMA CLASSICA E LA VARIANTE “RHUPUS” 92
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 91
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 86
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 84
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 80
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 78
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 78
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 78
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 78
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 77
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 77
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years 77
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 77
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 76
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 76
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 74
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 73
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 71
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 70
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 69
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 69
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 69
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 68
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 68
Sarilumab use in severe SARS-CoV-2 pneumonia 68
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 66
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 66
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 66
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 65
Validation of the classification criteria for cryoglobulinaemic vasculitis 64
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 64
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 63
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 63
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 61
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 61
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 61
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 61
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 61
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial 60
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 60
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 60
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 60
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 59
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 59
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 59
Residual respiratory impairment after COVID-19 pneumonia 59
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 58
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 57
Position paper of Italian rheumatologists on the use of biosimilar drugs 57
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 57
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 57
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 56
B cell activating factor (BAFF) and BAFF receptors: fakes and facts 56
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 56
Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles (of the responders). 55
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 55
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 55
Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement 54
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 54
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 54
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 54
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 53
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 53
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 53
Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA) 52
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 52
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry 52
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 52
[Class IV-G and IV-S lupus nephritis, interstitial infiltrates and prognosis: state of the art and unmet medical needs] 51
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 50
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 49
Obesity reduces the response rate to anti TNFα in rheumatoid arthritis. an approach to a personalized medicine 48
Totale 9.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019203 0 0 0 0 0 0 0 0 0 0 125 78
2019/20201.909 265 161 128 215 156 248 146 112 109 100 166 103
2020/20211.425 100 111 251 103 147 87 114 21 164 98 187 42
2021/20221.752 198 110 56 104 110 54 40 224 88 127 258 383
2022/20233.979 450 465 353 665 322 508 192 277 444 97 126 80
2023/20241.655 85 544 82 98 89 337 187 85 34 112 2 0
Totale 12.822